Does scopolamine improve attention more than placebo in healthy volunteers and what does this tell us about mechanisms of attention?
Does scopolamine improve selective attention and cognition more than placebo in healthy male volunteers?
The University of Queensland
25 participants
Jun 20, 2011
Interventional
Conditions
Summary
Attentional processing is a cognitive skill that allows us to interpret and act in our environment. Although this skill is important, little is understoond about the neurochemical processes that are important to attention. This study will allow us to assess the importance of different brain chemicals in contributing to selective attention function.
Eligibility
Inclusion Criteria3
- Healthy volunteers
- Aged 18-40 years
- Male
Exclusion Criteria4
- Current psychiatric or neurological diagnosis
- Current use of psychotropic medication
- Current use of cholinergic or anticholinergic medication
- Medical condition in which scopolamine is contraindicated
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A single dose of scopolamine (0.8mg contained in one capsule) (1-2 week washout between conditions)
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12611000603910